Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 303

1.

Functional evaluation of isocitrate dehydrogenase 1 and 2 variants of unclear significance in chronic myeloid neoplasms.

Tischer A, Antelo G, Coltro G, Finke CM, Gonsalves W, Pardanani A, Ketterling R, Mangaonkar A, Gangat N, Tefferi A, Patnaik MM, Lasho TL.

Leuk Res. 2019 Oct 24;87:106264. doi: 10.1016/j.leukres.2019.106264. [Epub ahead of print] No abstract available.

PMID:
31706195
2.

Cutaneous blastic plasmacytoid dendritic cell neoplasm arising in the context of TET2 and ZRSR2 mutated clonal cytopenias of unknown significance, secondary to somatic copy number losses involving CDK2NA/2NB and MTAP.

Li M, Shah M, Binder M, Lasho T, Carr R, Mangaonkar A, Gangat N, Coltro G, Tefferi A, Dao L, Peters M, Chiu A, Patnaik MM.

Am J Hematol. 2019 Nov 9. doi: 10.1002/ajh.25675. [Epub ahead of print] No abstract available.

PMID:
31705546
3.

Genetic and epigenetic factors interacting with clonal hematopoiesis resulting in chronic myelomonocytic leukemia.

Carr RM, Patnaik MM.

Curr Opin Hematol. 2019 Nov 4. doi: 10.1097/MOH.0000000000000553. [Epub ahead of print]

PMID:
31688455
4.

Bone marrow findings in Erdheim-Chester disease: increased prevalence of chronic myeloid neoplasms.

Goyal G, Ravindran A, Liu Y, He R, Shah MV, Bennani NN, Patnaik MM, Rech KL, Go RS; Mayo Clinic Hisiocytosis Working Group.

Haematologica. 2019 Oct 17. pii: haematol.2019.234187. doi: 10.3324/haematol.2019.234187. [Epub ahead of print]

5.

Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U): single center experience.

Baidoun F, Chen D, Patnaik M, Gangat N, Begna K, Elliott M, Hogan W, Litzow M, Al-Kali A.

Leuk Lymphoma. 2019 Oct;60(10):2483-2487. doi: 10.1080/10428194.2019.1581930. Epub 2019 Mar 7.

PMID:
31609151
6.

PD-1/PD-L1 expression in extramedullary lesions of acute myeloid leukemia.

Meleveedu KS, Chen D, Nadiminti K, Sidiqi H, Khan S, Alkhateeb H, Shah MV, Patnaik M, Hogan WJ, Begna K, Litzow M.

Leuk Lymphoma. 2019 Oct 12:1-4. doi: 10.1080/10428194.2019.1675880. [Epub ahead of print] No abstract available.

PMID:
31608729
7.

A case of potentially lethal vascular variation in association with palmaris profundus muscle.

Gaikwad MR, Ravi PK, Patnaik M.

Anat Cell Biol. 2019 Sep;52(3):349-353. doi: 10.5115/acb.19.061. Epub 2019 Aug 26.

8.

Correction to: Hybridization capture-based next-generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis.

He R, Devine DJ, Tu ZJ, Mai M, Chen D, Nguyen PL, Oliveira JL, Hoyer JD, Reichard KK, Ollila PL, Al-Kali A, Tefferi A, Begna KH, Patnaik MM, Alkhateeb H, Viswanatha DS.

Mod Pathol. 2019 Oct 7. doi: 10.1038/s41379-019-0378-6. [Epub ahead of print]

PMID:
31591496
9.

Advances in chronic myelomonocytic leukemia and future prospects: Lessons learned from precision genomics.

Mangaonkar AA, Patnaik MM.

Adv Cell Gene Ther. 2019 Apr;2(2). pii: e48. doi: 10.1002/acg2.48. Epub 2019 Jan 16.

PMID:
31559392
10.

Association between anemia and hematological indices with mortality among cardiac intensive care unit patients.

Rayes HA, Vallabhajosyula S, Barsness GW, Anavekar NS, Go RS, Patnaik MS, Kashani KB, Jentzer JC.

Clin Res Cardiol. 2019 Sep 18. doi: 10.1007/s00392-019-01549-0. [Epub ahead of print]

PMID:
31535171
11.

Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients.

Mangaonkar AA, Swoboda DM, Coltro G, Lasho TL, Novotny PJ, Pophali P, Carr RM, Binder M, Finke CM, Gangat N, Al-Kali A, Begna KH, Reichard KK, Ketterling RP, Al Ali NH, Vafaii P, Zhang L, Padron E, Talati C, Patnaik MM.

Leukemia. 2019 Sep 11. doi: 10.1038/s41375-019-0574-x. [Epub ahead of print] No abstract available.

PMID:
31511613
12.

Concomitant Erdheim-Chester disease and chronic myelomonocytic leukaemia: genomic insights into a common clonal origin.

Goyal G, Liu Y, Ravindran A, Al-Kali A, Go RS, Patnaik MM, Rech KL; Mayo Clinic Histiocytosis Working Group.

Br J Haematol. 2019 Oct;187(2):e51-e54. doi: 10.1111/bjh.16177. Epub 2019 Sep 2. No abstract available.

PMID:
31475353
13.

Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis.

He R, Devine DJ, Tu ZJ, Mai M, Chen D, Nguyen PL, Oliveira JL, Hoyer JD, Reichard KK, Ollila PL, Al-Kali A, Tefferi A, Begna KH, Patnaik MM, Alkhateeb H, Viswanatha DS.

Mod Pathol. 2019 Aug 30. doi: 10.1038/s41379-019-0359-9. [Epub ahead of print] Erratum in: Mod Pathol. 2019 Oct 7;:.

PMID:
31471587
14.

Iron deficiency anemia associated with extracorporeal photopheresis: A retrospective analysis.

Kuhn AK, Bartoo GT, Dierkhising RA, Mara KC, Winters JL, Patnaik MM, Gastineau DA, Adamski J, Merten JA.

J Clin Apher. 2019 Dec;34(6):666-671. doi: 10.1002/jca.21744. Epub 2019 Aug 22.

PMID:
31436854
15.

Practical limitations of monocyte subset repartitioning by multiparametric flow cytometry in chronic myelomonocytic leukemia.

Pophali PA, Timm MM, Mangaonkar AA, Shi M, Reichard K, Tefferi A, Pavelko K, Villasboas JC, Jevremovic D, Patnaik MM.

Blood Cancer J. 2019 Aug 16;9(9):65. doi: 10.1038/s41408-019-0231-7. No abstract available.

16.

Etiologies of Extreme Thrombocytosis: A Contemporary Series.

Hsieh RW, Ravindran A, Hook CC, Begna KH, Ashrani AA, Pruthi RK, Marshall AL, Hogan W, Litzow M, Hoyer J, Oliveira JL, Vishnu P, Call TG, Al-Kali A, Patnaik M, Gangat N, Pardanani A, Tefferi A, Go RS.

Mayo Clin Proc. 2019 Aug;94(8):1542-1550. doi: 10.1016/j.mayocp.2019.01.041.

PMID:
31378229
17.

Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013.

Al-Kali A, Zblewski D, Foran JM, Patnaik MS, Larrabee BR, Gangat N, Begna KH, Elliott MA, Hogan WJ, Tefferi A, Litzow MR, Go RS.

Mayo Clin Proc. 2019 Aug;94(8):1467-1474. doi: 10.1016/j.mayocp.2019.02.029.

PMID:
31378228
18.

QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia.

Barreto JN, Cullen MW, Mara KC, Grove ME, Sierzchulski AG, Dahl NJ, Tosh PK, Dierkhising RA, Patnaik MM, Ackerman MJ.

Leuk Lymphoma. 2019 Jul 12:1-9. doi: 10.1080/10428194.2019.1639165. [Epub ahead of print]

PMID:
31298598
19.

Clinical Applications and Utility of a Precision Medicine Approach for Patients With Unexplained Cytopenias.

Mangaonkar AA, Ferrer A, Pinto E Vairo F, Cousin MA, Kuisle RJ, Gangat N, Hogan WJ, Litzow MR, McAllister TM, Klee EW, Lazaridis KN, Stewart AK, Patnaik MM.

Mayo Clin Proc. 2019 Sep;94(9):1753-1768. doi: 10.1016/j.mayocp.2019.04.007. Epub 2019 Jun 27.

PMID:
31256854
20.

Phenotypic heterogeneity associated with germline GATA2 haploinsufficiency: a comprehensive kindred study.

Haddox CL, Carr RM, Abraham RS, Perez Botero J, Rodriguez V, Pardanani A, Patnaik MM.

Leuk Lymphoma. 2019 Jun 27:1-5. doi: 10.1080/10428194.2019.1633630. [Epub ahead of print] No abstract available.

PMID:
31246134

Supplemental Content

Loading ...
Support Center